Veterinary Point-of-Care Diagnostics

Global Veterinary Point-of-Care Diagnostics Market to Reach US$4.4 Billion by 2030

The global market for Veterinary Point-of-Care Diagnostics estimated at US$2.5 Billion in the year 2024, is expected to reach US$4.4 Billion by 2030, growing at a CAGR of 10.0% over the analysis period 2024-2030. Companion Animals, one of the segments analyzed in the report, is expected to record a 11.2% CAGR and reach US$3.1 Billion by the end of the analysis period. Growth in the Livestock Animals segment is estimated at 7.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$674.1 Million While China is Forecast to Grow at 13.9% CAGR

The Veterinary Point-of-Care Diagnostics market in the U.S. is estimated at US$674.1 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$906.9 Million by the year 2030 trailing a CAGR of 13.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.1% and 8.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.9% CAGR.

Global Veterinary Point-of-Care Diagnostics Market – Key Trends & Drivers Summarized

Why Is Veterinary Point-of-Care Diagnostics Becoming Essential in Animal Healthcare?

Veterinary point-of-care (POC) diagnostics have revolutionized the way veterinarians diagnose and manage diseases, enabling rapid and accurate on-site testing without the need for external laboratory facilities. With increasing pet ownership and growing awareness of preventive healthcare, veterinarians and pet owners alike are demanding faster diagnostic solutions that allow for immediate treatment decisions. The ability to diagnose conditions such as infections, organ dysfunction, metabolic disorders, and infectious diseases within minutes has significantly improved the efficiency of veterinary care. Additionally, the rise in zoonotic diseases has heightened the importance of early disease detection, particularly in livestock and food-producing animals where timely intervention can prevent outbreaks and safeguard public health. Equine and exotic animal veterinarians are also benefiting from POC diagnostics, as these portable devices enable field testing in remote locations without access to traditional laboratory infrastructure. The shift towards evidence-based veterinary medicine is further driving the adoption of POC diagnostic tools, allowing veterinarians to provide data-driven treatment plans with greater accuracy and confidence.

What Are the Latest Innovations in Veterinary Point-of-Care Testing?

Advancements in veterinary POC diagnostics have led to the development of highly sophisticated testing devices that offer greater accuracy, efficiency, and ease of use. One of the most notable breakthroughs is the introduction of portable analyzers that can conduct a wide range of tests, including hematology, biochemistry, and electrolyte analysis, within a single compact system. The integration of artificial intelligence (AI) and machine learning algorithms into POC devices is enhancing diagnostic accuracy by reducing human error and automating result interpretation. Additionally, the development of immunoassay-based rapid test kits for conditions such as parvovirus, heartworm disease, feline leukemia, and tick-borne infections has made disease detection more accessible in routine veterinary practice. The rise of microfluidic-based diagnostic platforms has further improved the precision and speed of testing, allowing for real-time blood analysis with minimal sample volumes. Another major innovation is the growing adoption of cloud-connected POC devices, enabling veterinarians to store and share test results instantly with specialists for remote consultation and second opinions. As these technological advancements continue to evolve, POC diagnostics are becoming an integral component of modern veterinary practice, providing immediate and actionable insights for improved patient care.

What Challenges Exist in the Veterinary Point-of-Care Diagnostics Market?

Despite its rapid adoption, the veterinary POC diagnostics market faces several challenges that impact its growth and accessibility. One of the primary concerns is the cost of advanced POC testing equipment, which can be a financial burden for small and independent veterinary clinics. While these devices offer long-term benefits, the initial investment and ongoing consumable costs can limit adoption, particularly in developing regions. Additionally, the accuracy and reliability of some POC tests remain a concern, as variations in sample quality, operator proficiency, and environmental factors can impact test results. Regulatory approval processes for new diagnostic technologies also present challenges, as stringent validation protocols are required to ensure compliance with veterinary health standards. Another obstacle is the limited availability of species-specific diagnostic tests, as many POC devices are designed for commonly treated animals such as dogs and cats, leaving a gap in diagnostics for exotic and wildlife species. Furthermore, the lack of standardization among different POC testing platforms can create interoperability issues, making it difficult for veterinarians to integrate results into centralized patient records. Overcoming these challenges requires continued research, cost-effective product development, and enhanced training for veterinarians and technicians to maximize the potential of POC diagnostic tools.

What Are the Key Growth Drivers of the Veterinary Point-of-Care Diagnostics Market?

The growth in the veterinary POC diagnostics market is driven by several factors, including increasing demand for rapid and accurate testing, rising pet healthcare expenditures, and advancements in diagnostic technology. The expansion of companion animal healthcare services has led to a greater emphasis on immediate diagnosis and treatment, fueling the demand for POC devices that enhance clinical decision-making. The growing prevalence of chronic diseases, such as diabetes and kidney disorders in pets, has further driven the need for on-site diagnostic monitoring solutions. In livestock and poultry industries, the push for disease prevention and food safety has accelerated the adoption of portable testing kits that enable real-time monitoring of herd and flock health. The increasing availability of cloud-based data sharing and telemedicine integration is also playing a significant role in market expansion, allowing veterinarians to make more informed treatment decisions remotely. Additionally, the rising number of veterinary diagnostic startups and investments in veterinary health technology are contributing to the development of innovative POC solutions that cater to a broader range of animal species. With ongoing advancements and growing awareness of the benefits of rapid diagnostics, the veterinary POC diagnostics market is expected to experience significant growth in the coming years.

SCOPE OF STUDY:

The report analyzes the Veterinary Point-of-Care Diagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Animal Type (Companion Animals, Livestock Animals); Product (Consumables, Reagents, & Kits, Instruments & Devices); Testing Category (Hematology, Diagnostic Imaging, Bacteriology, Virology, Cytology, Clinical Chemistry, Parasitology, Serology, Others); Sample Type (Infectious Disease, General Ailments, Others); Indication (Blood / Plasma / Serum, Urine, Fecal, Others)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 48 Featured) -

• Agrolabo S.p.A.
• AniPOC Ltd.
• bioMérieux SA
• BioNote, Inc.
• Covetrus
• Deciphex Limited
• ESAOTE S.p.A.
• FUJIFILM Corporation
• Getein Biotech
• Heska Corporation
• IDEXX Laboratories, Inc.
• iM3Vet Pty Ltd.
• INDICAL BIOSCIENCE GmbH
• Merck KGaA
• Mindray Animal Medical Technology
• Neogen Corporation
• NeuroLogica Corp.
• Randox Laboratories Ltd.
• Scopio Labs
• Techcyte

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.